Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous immunoglobulin versus placebo in CIDP
2009-013930-25Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing Subcutaneous immunoglobulin with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Sep 2009; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2009-013930-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013930-25.